Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trialSi‐Yang Maggie Liu, Yi‐Long Wu, Zhen Wang et al.|EClinicalMedicine|2023Cited by 11